Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe
News
The European Commission (EC) has approved Adcetris (brentuximab vedotin) when used alongside chemotherapy as a first treatment for adults with systemic anaplastic large cell lymphoma (sALCL), a type of peripheral T-cell ... Read more